MenoSphora^®

Introducing MenoSphora^®

MenoSphora^® is a clinically tested, standardized, and full-spectrum extract from Sophora japonica containing sophoricoside. MenoSphora® is manufactured using Botanic Healthcare’s unique extraction process, yielding the optimum percentage of active phytoconstituents required for the high efficacy of this product.

Active ingredient Sophoricoside

Clinical study details

A pilot study was conducted to evaluate the safety and efficacy of MenoSphora^® in post-menopausal women.

• Condition: Post-menopausal women
• Participants: 30 subjects (aged 45-55 years)
• Duration: 12 weeks
• Dosage: 600mg per day in a divided dose
• Download: Download the full report

Effect of MenoSphora^® 

MenoSphora^® improved the Kupperman Index (KI) and Visual analog scale (VAS) scores. There was a significant improvement in somatic and psychological symptoms related to menopause when compared to the placebo group.

Clinical study outcomes

The subjective and objective evaluation of MenoSphora^® in post-menopausal women subjects revealed that the given oral dose of 600mg a day for 12 weeks was found to be safe and tolerable.

We assure you

Botanic Healthcare manufactures in a cGMP and ISO certified facility. Our products are certified kosher and halal. BSE/TSE Certificate: Allergen free, non-GMO, gluten free, and non-irradiated.